Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

NEURONAD

Financiado

Cerrado

Isoform specific functions of NAD synthesising enzyme NMNAT in compartmentalised...

Isoform specific functions of NAD synthesising enzyme NMNAT in compartmentalised neuronal death "Nicotinamide mononucleotide adenylyltransferase (NMNAT) is the central enzyme in NAD biosynthetic pathways. Among the three known mammalian isozymes, nuclear NMNAT1 generates NAD which is used as substrate for the enzymes SIRT1 a... ver más

31/07/2014

THE UNIVERSITY OF...

270K€

Presupuesto del proyecto: 270K€

Líder del proyecto

THE UNIVERSITY OF NOTTINGHAM No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2014-07-31 No tenemos la información de la convocatoria

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

THE UNIVERSITY OF NOTTINGHAM

0.00€ | Lider

Proyectos interesantes

REGUNMNAT1

Medical Technol...

Applied Physics

231K€ Cerrado

SAF2012-39852-C02-02

Medical Technol...

Applied Physics

105K€ Cerrado

SAF2009-13093-C02-02

Medical Technol...

Applied Physics

182K€ Cerrado

SAF2012-39852-C02-01

Medical Technol...

Applied Physics

94K€ Cerrado

BFU2016-77634-R

Medical Technol...

Applied Physics

109K€ Cerrado

SAF2017-87595-R

Medical Technol...

Applied Physics

143K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

THE UNIVERSITY OF NOTTINGHAM No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 270K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto "Nicotinamide mononucleotide adenylyltransferase (NMNAT) is the central enzyme in NAD biosynthetic pathways. Among the three known mammalian isozymes, nuclear NMNAT1 generates NAD which is used as substrate for the enzymes SIRT1 and PARP1, involved in transcription control and DNA damage repair and associated to cell death and senescence. Various data suggest that NMNAT1 could be neuroprotective: SIRT1 activation or overexpression confers neuroprotection in various models of neurodegenerative diseases; PARP1 mild activation is neuroprotective; finally, the overexpression of NAMPT, an enzyme producing an NMNAT substrate, also confers neuroprotection. However, NMNAT1 requirement for neuron maintenance has not yet been directly demonstrated. NMNAT2 instead, located prevalently in the cytoplasm in association with the Golgi apparatus, acts as a survival factor for axons and synapses, which degenerate when NMNAT2 is rapidly degraded after an injury. NMNAT enzyme activity is necessary for axon protection, but the mechanism involved is still unclear. These data led us to the hypothesis that NMNAT activity is required for the survival of distinct neuronal compartments and that the two isoforms NMNAT1 and NMNAT2 locally provide for this activity in the cell nucleus and in the axon, respectively. This project will combine the enzymology skills of the IEF applicant with the neurobiology and molecular genetics expertise of the host laboratory to test this hypothesis by generating a neuron-specific conditional knockout (KO) mouse for NMNAT1 using the Cre-loxP system and by studying the mechanism of NMNAT2-mediated neuroprotection in primary neurons. Our results will identify NMNAT enzymes as targets for pharmacological intervention in neurodegeneration. This study will be achieved by the mobility of the IEF fellow, who will acquire as a result a combination of disciplines and techniques key to his career development as an independent scientist."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores